The stock of Genprex, Inc. (NASDAQ:GNPX) is now priced at $3.96 and the shares are 0.08 points up or 2.06% higher compared to its previous closing price of $3.88. The stock had 1.091 million contracts set over the past session. GNPX shares’ daily volume is compared to its average trading volume at 1.801 million shares. However, it has a float of 31.32 million and although its performance was 0.76% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the GNPX share price recently placing at $3.77 to $4.09. However, some brokerage firms have priced the stock below the average, including one that has called $7.
The shorts are running away from the Genprex, Inc. stock, with the latest data on short interest released on August 14, 2020, showing that short interest numbers in the GNPX shares have declined. Short interest in the stock represents just 11.34% of its float, but the volume has dropped by -387120. The volume of shorted shares dropped to 3.55 million from 3.937 million shares over the last two weeks. The average intraday trading volume has been 610372 shares, which means that days to cover moved to roughly 5.816091.
In the last trading session, Genprex, Inc. (NASDAQ:GNPX) raised by $0.03 over the week and gained $0.25 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $7.03. The stock recorded its established 52-week high on 02/25/20.
Since 12/11/19, the stock has traded to a low of $0.23 at 1614.29%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge.
Looking at current readings, Genprex, Inc.’s two-week RSI is 55.99. This suggests that the stock is neutral at the moment and that GNPX shares’ price movement remains stable. The stochastic readings are equally revealing at 43.16% meaning the GNPX share price is currently in neutral territory.
The technical chart shows that the GNPX stock will likely settle at between $4.11 and $4.26 per share. However, if the stock dips below $3.79, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $3.62.
Currently, the stock is trading in the red of MACD, with a reading of -0.01. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.
Analysts at Maxim Group assigned GNPX a rating of Outperform in their intiating review released on April 29.
The average rating for the GNPX equity is 2 and is currently gathering a bullish momentum. Of 2 analysts tracking Genprex, Inc. polled by Reuters, 0 rated GNPX as a hold. The remaining 2 analysts were split evenly. However, the split wasn’t equal as a majority (2) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.
Elsewhere, the GNPX stock price is 15.84X ahead of its 12-month Consensus earnings per share estimates.